Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Compounded Preparations Bremelanotide is the active compound in the FDA-approved medication Vyleesi (Cosette Pharmaceuticals), indicated for HSDD in premenopausal women
Other TRIUMPH Trials Additional Phase 3 trials in the TRIUMPH program are ongoing: TRIUMPH-1: Retatrutide in obesity (general population), results expected 2026 TRIUMPH-2: Retatrutide in type 2 diabetes, results expected 2026 TRIUMPH-3: Retatrutide cardiovascular outcomes trial, results expected 2027 Visualize Your Retatrutide Journey See how retatrutide builds up in your system over time and compare different dosing protocols
Both strength and aerobic fitness (as measured by VO2 max) are roughly proportional to muscle mass, so your absolute fitness might appear to decline when you lose a lot of weight
Drink enough water Eat your veggies and fruits (especially those rich in vitamin C, like oranges, guavas, and strawberries)
Once synthesized, MOTS-c is actively transported out of the mitochondria and into the nucleus during conditions like exercise or metabolic stress
